Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.34 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.33 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22386945 | 1.00 | MEN1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22386822 | 0.99 | MEN1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22386882 | 0.94 | MEN1 (0.39) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL14749063 | 0.94 | KDM4E (0.40) | MEN1KMT2AL3MBTL1KDM4EATM | |
| SCHEMBL14749053 | 0.94 | KDM4E (0.40) | MEN1KMT2AL3MBTL1KDM4EATM | |
| SCHEMBL14749042 | 0.94 | KDM4E (0.41) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL14749046 | 0.94 | KDM4E (0.41) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22386946 | 0.93 | KDM4E (0.37) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL22386949 | 0.93 | KDM4E (0.37) | MEN1KMT2AALDH1A1MAPTHPGD | |
| SCHEMBL21472225 | 0.93 | MEN1 (0.36) | MEN1KMT2AALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708356-B2 | Organic electroluminescent materials and devices | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-25 | — | — | US | disclosed |
| US-11708356-B2 | Organic electroluminescent materials and devices | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-07-25 | — | — | US | disclosed |
| US-20200277283-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2020-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708356-B2 | Organic electroluminescent materials and devices | VDAC3, VDAC2, VDAC1 | MEN1 2921/4885KMT2A 2073/4885ALDH1A1 2594/4885 |
| US-20200277283-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | VDAC3, VDAC2, VDAC1 | MEN1 2921/4885KMT2A 2073/4885ALDH1A1 2594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.